720 related articles for article (PubMed ID: 22681425)
41. Adherence to Recommended Practices for Provision of Long-Acting Reversible Contraception Among Providers in a Large U.S. Health Care System.
Judge-Golden CP; Wiesenfeld HC; Chen BA; Borrero S
J Womens Health (Larchmt); 2020 Dec; 29(12):1586-1595. PubMed ID: 32667847
[No Abstract] [Full Text] [Related]
42. Plan A: postabortion contraception.
Micks E; Prager S
Clin Obstet Gynecol; 2014 Dec; 57(4):751-62. PubMed ID: 25254920
[TBL] [Abstract][Full Text] [Related]
43. Satisfaction, early removal, and side effects associated with long-acting reversible contraception.
Dickerson LM; Diaz VA; Jordon J; Davis E; Chirina S; Goddard JA; Carr KB; Carek PJ
Fam Med; 2013; 45(10):701-7. PubMed ID: 24347187
[TBL] [Abstract][Full Text] [Related]
44. Use of Highly Effective Reversible Contraception in Title X Clinics: Variation by Selected State Characteristics.
Hale N; Khoury A; Smith M
Womens Health Issues; 2018; 28(4):289-296. PubMed ID: 29661696
[TBL] [Abstract][Full Text] [Related]
45. Game change in Colorado: widespread use of long-acting reversible contraceptives and rapid decline in births among young, low-income women.
Ricketts S; Klingler G; Schwalberg R
Perspect Sex Reprod Health; 2014 Sep; 46(3):125-32. PubMed ID: 24961366
[TBL] [Abstract][Full Text] [Related]
46. Development and testing of an iOS waiting room "app" for contraceptive counseling in a Title X family planning clinic.
Gilliam ML; Martins SL; Bartlett E; Mistretta SQ; Holl JL
Am J Obstet Gynecol; 2014 Nov; 211(5):481.e1-8. PubMed ID: 24881829
[TBL] [Abstract][Full Text] [Related]
47. Contraceptive development and better family planning.
Segal SJ
Bull N Y Acad Med; 1996; 73(1):92-104. PubMed ID: 8804742
[TBL] [Abstract][Full Text] [Related]
48. Attitudes towards long-acting reversible methods of contraception in general practice in the UK.
Wellings K; Zhihong Z; Krentel A; Barrett G; Glasier A
Contraception; 2007 Sep; 76(3):208-14. PubMed ID: 17707718
[TBL] [Abstract][Full Text] [Related]
49. Society for Maternal-Fetal Medicine (SMFM) Consult Series #48: Immediate postpartum long-acting reversible contraception for women at high risk for medical complications.
; Vricella LK; Gawron LM; Louis JM
Am J Obstet Gynecol; 2019 May; 220(5):B2-B12. PubMed ID: 30738885
[TBL] [Abstract][Full Text] [Related]
50. Interdependent Barriers to Providing Adolescents with Long-Acting Reversible Contraception: Qualitative Insights from Providers.
Murphy MK; Stoffel C; Nolan M; Haider S
J Pediatr Adolesc Gynecol; 2016 Oct; 29(5):436-442. PubMed ID: 26851537
[TBL] [Abstract][Full Text] [Related]
51. Evaluating the impact of a quality management intervention on post-abortion contraceptive uptake in private sector clinics in western Kenya: a pre- and post-intervention study.
Wendot S; Scott RH; Nafula I; Theuri I; Ikiugu E; Footman K
Reprod Health; 2018 Jan; 15(1):10. PubMed ID: 29351797
[TBL] [Abstract][Full Text] [Related]
52. Familiarity with Long-acting Reversible Contraceptives among Obstetrics and Gynecology, Family Medicine, and Pediatrics Residents: Results of a 2015 National Survey and Implications for Contraceptive Provision for Adolescents.
Davis SA; Braykov NP; Lathrop E; Haddad LB
J Pediatr Adolesc Gynecol; 2018 Feb; 31(1):40-44. PubMed ID: 28942106
[TBL] [Abstract][Full Text] [Related]
53. Acceptability of IUDs is increasing.
Finger WR; Barr D
Netw Res Triangle Park N C; 1992 Oct; 13(2):27-30. PubMed ID: 12286082
[TBL] [Abstract][Full Text] [Related]
54. Regional variation in postabortion initiation of long-acting reversible contraception in New Zealand.
Rose SB; Garrett SM
Aust N Z J Obstet Gynaecol; 2016 Jun; 56(3):315-22. PubMed ID: 27060549
[TBL] [Abstract][Full Text] [Related]
55. General practitioners' views on the use of the levonorgestrel-releasing intrauterine system in young, nulligravid women, in London, UK.
Middleton AJ; Naish J; Singer N
Eur J Contracept Reprod Health Care; 2011 Aug; 16(4):311-8. PubMed ID: 21585243
[TBL] [Abstract][Full Text] [Related]
56. Findings and Lessons Learned From Strengthening the Provision of Voluntary Long-Acting Reversible Contraceptives With Postabortion Care in Guinea.
Pfitzer A; Hyjazi Y; Arnold B; Aribot J; Hobson RD; Pleah TG; Turke S; O'Colmain B; Arscott-Mills S
Glob Health Sci Pract; 2019 Aug; 7(Suppl 2):S271-S284. PubMed ID: 31455624
[TBL] [Abstract][Full Text] [Related]
57. Service delivery characteristics associated with contraceptive use among youth clients in integrated voluntary counseling and HIV testing clinics in Kenya.
Baumgartner JN; Otieno-Masaba R; Weaver MA; Grey TW; Reynolds HW
AIDS Care; 2012; 24(10):1290-301. PubMed ID: 22435668
[TBL] [Abstract][Full Text] [Related]
58. Impact of years of clinical experience on perceived contraindications and barriers to the use of LARC: a survey of family planning providers.
Philliber AE; Hirsch H; Mortillaro L; Turner R; Arons A; Philliber S
Womens Health Issues; 2014; 24(5):503-9. PubMed ID: 25213743
[TBL] [Abstract][Full Text] [Related]
59. Long-Acting Reversible Contraception Counseling and Use for Older Adolescents and Nulliparous Women.
Gibbs SE; Rocca CH; Bednarek P; Thompson KMJ; Darney PD; Harper CC
J Adolesc Health; 2016 Dec; 59(6):703-709. PubMed ID: 27665153
[TBL] [Abstract][Full Text] [Related]
60. Effect of previous induced abortions on postabortion contraception selection.
Keene M; Roston A; Keith L; Patel A
Contraception; 2015 May; 91(5):398-402. PubMed ID: 25637863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
